Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-001275
Filing Date
2022-01-06
Accepted
2022-01-06 20:26:30
Documents
2
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1564
2 EX-24 DOCUMENT attachment1.htm EX-24 4761
  Complete submission text file 0000899243-22-001275.txt   7742
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-254-4445
Vigil Neuroscience, Inc. (Issuer) CIK: 0001827087 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NORTHPOND VENTURES 7500 OLD GEORGETOWN ROAD BETHESDA MD 20814
Business Address
Gandhi Shaan-Chirag C (Reporting) CIK: 0001873448 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41200 | Film No.: 22516254